Archives
-
Z-VAD-FMK as a Causal Probe in Pyroptosis
2026-09-08
Z-VAD-FMK is more than an apoptosis inhibitor: it can help map where caspase-dependent signaling intersects with pyroptotic cell death. This guide translates recent GA2–caspase-11 findings into practical assay and interpretation strategies.
-
Octenidine dihydrochloride Research Workflow
2026-09-08
Build reproducible membrane-disruption, antimicrobial, and antibiofilm screens with Octenidine dihydrochloride. This workflow combines practical formulation guidance with reference-study insights on octenidine-derived gemini compounds, helping researchers separate solubility, exposure, and biological effects.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-09-07
The reference study shows that CDC42-dependent epithelial polarity controls the intestinal stem cell-to-transit-amplifying cell transition through a YAP/TAZ–epiregulin–mTOR signaling cascade, rather than through canonical Wnt signaling alone. Its genetic and pharmacological rescue experiments separate polarity maintenance from cell-fate regulation and provide a useful framework for studying intestinal epithelial homeostasis.
-
Hypoxia, Immunometabolism, and Tumor Redox Biology
2026-09-07
This 2025 review presents tumor hypoxia and immunometabolism as a reinforcing system in which oxygen limitation, nutrient competition, and immune-cell metabolic dysfunction promote an immunosuppressive tumor microenvironment. Its main practical contribution is a mechanistic framework for designing studies that connect hypoxia signaling, metabolic phenotypes, immune function, and redox measurements without treating these variables as isolated endpoints.
-
WAY-100635: 5-HT1A Antagonist Research Guide
2026-09-05
WAY-100635 is a selective, silent 5-HT1A receptor antagonist for serotonin receptor antagonist research and neuroscience receptor pharmacology. Its reported nanomolar binding potency, functional antagonism, and in vivo activity support use as a mechanistic control, while its imaging and cannabinoid-serotonin applications require careful evidence boundaries.
-
L-NAME Hydrochloride: Assay Workflows
2026-09-04
Build more informative nitric oxide experiments with L-NAME Hydrochloride, from cell-based inflammation assays to vascular tone regulation studies. The workflow emphasizes dose justification, orthogonal readouts, rescue controls, and clear separation between NO-dependent effects and broader cytotoxic or inflammatory responses.
-
Light-Inducible RNA Release for Gene Therapy
2026-09-04
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls mammalian translation by retaining regulatory RNA in darkness and releasing it under blue or ambient light. In mouse models, LIRP-enabled AAV gene switches regulated therapeutic activity in skin and retina, illustrating a route toward more timely and interruptible gene therapies.
-
Ciprofloxacin as a Lens on Resistance Transmission
2026-09-03
Ciprofloxacin is more than a susceptibility-test control: it can connect DNA-target engagement with plasmid mobility, resistance architecture, and translational assay design. This thought-leadership article shows how to build antimicrobial resistance research workflows around mechanistic, genetic, and transmission-aware evidence.
-
Griseofulvin Workflows for Microtubule Research
2026-09-03
Use Griseofulvin as a practical probe for fungal microtubule disruption, mitotic arrest, and mechanism-focused antifungal screening. This workflow combines fungal phenotyping with a carefully limited mammalian-cell bridge inspired by a validated aneugen mechanism assay.
-
Hypoxia, Immunometabolism, and the Tumor Microenvironment
2026-09-02
This 2025 review frames tumor hypoxia as an active organizer of metabolic competition, immune dysfunction, and immunosuppressive microenvironmental remodeling rather than as an isolated oxygen deficit. Its main practical contribution is a mechanistic framework for designing experiments and therapies that jointly examine oxygen availability, nutrient use, immune-cell state, and tumor progression.
-
JC-1 Workflow for Mitochondrial Membrane Potential
2026-09-02
JC-1 converts mitochondrial polarization into a ratiometric green-to-red fluorescence signal, supporting apoptosis detection and mitochondrial dysfunction research. This practical guide connects assay setup, flow-cytometry controls, and troubleshooting to a pulmonary-fibrosis study investigating ferroptosis and mitochondrial injury.
-
Vitamin C (CAS 50-81-7) in Cell Assays
2026-09-01
This scenario-based guide explains how Vitamin C (CAS 50-81-7), SKU B2064, can support more reproducible viability, proliferation, cytotoxicity, and exploratory organoid workflows. It connects concentration-dependent CT26 findings with practical preparation, interpretation, cross-domain limitations, and evidence-based product selection.
-
SARS-CoV-2 N Protein, GADD34, and Atypical Foci
2026-09-01
The reference study identifies a mechanism by which SARS-CoV-2 nucleocapsid protein suppresses innate immunity: it redirects GADD34 mRNA into atypical N+/G3BP1+ foci, reducing GADD34-dependent IRF3 nuclear localization and interferon production. These findings refine the distinction between antiviral stress granules and proviral stress-like condensates and provide a useful framework for dissecting viral immune evasion.
-
Metal-Ion Enrichment Improves mRNA Vaccine Delivery
2026-08-31
The reference study introduces a manganese-mediated strategy for condensing mRNA into a dense core before lipid coating, nearly doubling payload loading compared with conventional LNP-mRNA formulations. The resulting L@Mn-mRNA system also improved cellular uptake and vaccine responses, while reducing the formulation burden associated with excess lipid components.
-
Rifampin: Mechanism and Research Workflows
2026-08-31
Rifampin is a rifamycin antibiotic and DNA-dependent RNA polymerase inhibitor that suppresses bacterial transcription. Its defined mechanism, resistance genetics, and solvent-dependent handling make it useful for bacterial resistance mechanism research, transcriptional regulation studies, and synthetic biology transcription inhibition.